Table 2 HIV-related markers while on immune checkpoint inhibitor therapy
Patient | cART regimen | plasma HIV viral load (copies/mL) at baseline | plasma HIV viral load (copies/mL) at 24 weeks | CD4+ T cell count (cells/μL) at baseline | CD4+ T cell count(cells/μL) at 24 weeks |
|---|---|---|---|---|---|
1 | TDF + LAM + EFV |  < 40 | NA | 171 | 159 |
2 | TDF + LAM + DTG | Not detected | Not detected | 156 | 137 |
3 | FTC + TAF + RAL |  < 40 | Not detected | 120 | 177 |
4 | TDF + LAM + EFV | Not detected | NA | 375 | NA |
5 | TDF + LAM + EFV | NA | NA | NA | NA |
6 | TDF + LAM + DTG | 159 | NA* | 317 | NA* |
7 | TDF + LAM + EFV |  < 40 | Not detected | 208 | 337 |
8 | TDF + DTG + FTC | 198 | 43.8 | 60 | NA |
9 | TDF + LAM + DTG | NA | NA* | 156 | NA* |
10 | TDF + LAM + EFV | NA | Not detected | NA | 824 |
11 | TDF + LAM + DTG | 2.18E + 5 | NA* | 120 | NA* |
12 | TDF + LAM + EFV | NA | NA* | 55 | NA* |
13 | BIC + FTC + TAF | NA | Not detected | 340 | 288 |
14 | TDF + LAM + EFV | NA | NA* | 155 | NA* |
15 | TDF + LAM + EFV | Not detected | Not detected | 121 | 206 |